11-Dehydro-thromboxane B2, a Stable Thromboxane Metabolite, Is a Full Agonist of Chemoattractant Receptor-homologous Molecule Expressed on TH2 Cells (CRTH2) in Human Eosinophils and Basophils-Reference-Cited by-同舟云学术

11-Dehydro-thromboxane B2, a Stable Thromboxane Metabolite, Is a Full Agonist of Chemoattractant Receptor-homologous Molecule Expressed on TH2 Cells (CRTH2) in Human Eosinophils and Basophils

Published:2004-02 Issue:9 Volume:279 Page:7663-7670
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Böhm Eva,Sturm Gunter J.,Weiglhofer Iris,Sandig Hilary,Shichijo Michitaka,McNamee Anne,Pease James E.,Kollroser Manfred,Peskar Bernhard A.,Heinemann Akos

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference54 articles.

1. The pathophysiology of allergic rhinitis: Impact of therapeutic intervention

2. Eosinophilic Inflammation in Asthma

3. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness

4. Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of 11-dehydro-thromboxane B2 time-resolved immunoassay and application in membranous nephropathy;Analytical Biochemistry;2023-09

2. Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin;Biomedicines;2023-01-25

3. Breaking down the complex pathophysiology of eosinophilic esophagitis;Annals of Allergy, Asthma & Immunology;2023-01

4. Skin-homing basophils and beyond;Frontiers in Immunology;2022-12-22

5. Treatment of COVID-19 Pneumonia and Acute Respiratory Distress With Ramatroban, a Thromboxane A2 and Prostaglandin D2 Receptor Antagonist: A Four-Patient Case Series Report;Frontiers in Pharmacology;2022-07-22